Thermo Fisher Acquires Microbiological Testing Firm | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it has acquired Trek Diagnostic Systems from Magellan Biosciences for an undisclosed amount.

Trek makes blood culture, microorganism identification, and antibiotic-susceptibility testing products for the pharmaceutical and clinical lab markets. The firm is based near Cleveland, has 150 employees, and had full-year 2010 revenues of $34 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.